Trial intelligence / Profile preview

Retinal Microvascular Network in Coronary Revascularization

NCT05315349Completed

Sponsor
Centre Hospitalier Universitaire Dijon Bourgogne
Start
Jun 2022
Primary completion
Apr 2025
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoint: Acute Kidney Injury rate at 7 days. Started Jun 2022; status: completed.

Beyond the preview

Go deeper on NCT05315349.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05315349.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call